Autopsy report · NCT02005133
A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 11 months before it stopped.
- 188 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Wet Age-related Macular Degeneration
- Participants
- 188
- Sites
- 17
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.